PureTech Net Income From Continuing Ops from 2010 to 2026
| PRTC Stock | USD 16.79 0.15 0.90% |
Net Income From Continuing Ops | First Reported 2010-12-31 | Previous Quarter 31.9 M | Current Value 33.5 M | Quarterly Volatility 109.9 M |
Check PureTech Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PureTech Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.9 M, Interest Expense of 6.7 M or Selling General Administrative of 27.2 M, as well as many indicators such as Price To Sales Ratio of 88.15, Dividend Yield of 2.0E-4 or PTB Ratio of 1.13. PureTech financial statements analysis is a perfect complement when working with PureTech Health Valuation or Volatility modules.
PureTech | Net Income From Continuing Ops | Build AI portfolio with PureTech Stock |
Latest PureTech Health's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of PureTech Health PLC over the last few years. It is PureTech Health's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PureTech Health's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
PureTech Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (24,417,820) | |
| Geometric Mean | 57,917,824 | |
| Coefficient Of Variation | (449.98) | |
| Mean Deviation | 68,941,196 | |
| Median | (70,659,000) | |
| Standard Deviation | 109,875,460 | |
| Sample Variance | 12072.6T | |
| Range | 447.7M | |
| R-Value | 0.37 | |
| Mean Square Error | 11107.3T | |
| R-Squared | 0.14 | |
| Significance | 0.14 | |
| Slope | 8,067,064 | |
| Total Sum of Squares | 193161.9T |
PureTech Net Income From Continuing Ops History
About PureTech Health Financial Statements
PureTech Health stakeholders use historical fundamental indicators, such as PureTech Health's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although PureTech Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in PureTech Health's assets and liabilities are reflected in the revenues and expenses on PureTech Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PureTech Health PLC. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 31.9 M | 33.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out the analysis of PureTech Health Correlation against competitors. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.615 | Earnings Share 1.7 | Revenue Per Share | Quarterly Revenue Growth 5.427 | Return On Assets |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.